Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
2.86M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
2.64K
-
Shares change
-
+2.45K
-
Total reported value, excl. options
-
$12.4K
-
Value change
-
+$11.5K
-
Number of buys
-
9
-
Price
-
$4.69
Significant Holders of Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) as of Q1 2024
10 filings reported holding APVO - Aptevo Therapeutics Inc. - Common Stock, $0.001 par value as of Q1 2024.
Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.64K shares
of 2.86M outstanding shares and own 0.09% of the company stock.
Largest 10 shareholders include Tower Research Capital LLC (TRC) (1.32K shares), BlackRock Inc. (890 shares), MORGAN STANLEY (194 shares), Qube Research & Technologies Ltd (100 shares), OSAIC HOLDINGS, INC. (45 shares), JPMORGAN CHASE & CO (43 shares), WELLS FARGO & COMPANY/MN (36 shares), FIFTH THIRD BANCORP (6 shares), PNC Financial Services Group, Inc. (3 shares), and Truvestments Capital LLC (2 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.